Medics have issued an urgent warning around an experimental weight loss medication which is currently undergoing clinical ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Megan Hancocks bought a drug labelled as the peptide compound retatrutide in cash from a beautician. Within a week of her second dose, she was in acute liver failure.

May 21 (UPI) --Eli Lilly said its weight loss drug, retatrutide, helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight. Many of the people who lost that much ...

A STAT News report said several clues pointed to the president being the unnamed 79-year-old man who received the drug.

Novo Nordisk is finally getting one up on its biggest rival.

Retatrutide is a triple agonist, meaning it targets three hormone receptor agonists: GLP-1, GIP and glucagon (GCG). It’s ...

Clinical trial results for retatrutide, Eli Lilly’s next weight loss drug, showed weight loss that’s on par with bariatric surgery. Trial participants lost an average of up to 71.2 pounds, far more ...

At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Lilly CEO Dave Ricks ...

The weight loss tailwind isn't about to come to a halt.